Tom John, Medical Oncologist and Translational Researcher at Peter MacCallum Cancer Centre, recently shared a post by International Association For The Study Of Lung Cancer (IASLC) on LinkedIn, adding:
“Lovely to launch this new International Association for the Study of Lung Cancer podcast. Each month we will be discussing key articles featured in the Journal of Thoracic Oncology. Hoping it will be a useful resource for patients and clinicians.”
Quoting International Association For The Study Of Lung Cancer (IASLC)՛s post:
“Introducing JTO Insights, the official podcast of the Journal of Thoracic Oncology!
Hosted by Dr. Alex Adjei and Dr. Tom John, JTO Insights brings you expert discussions of the most impactful research published in JTO.
Each episode explores:
- Selected articles from the latest issue
- The clinical significance of new research
- Emerging directions in thoracic oncology
In the first episode, two important studies from the April 2026 issue are explored:
Timothy F. Burns discusses the efficacy and safety of olomorasib in combination with Pembrolizumab for patients with KRAS G12C-mutant advanced NSCLC, while Paaladinesh Thavendiranathan examines cardiovascular risks in patients with thymoma or thymic carcinoma receiving cancer therapy.
Listen now.”
Other Articles Featuring Tom John And IASLC on OncoDaily.